Trial Details
COMPLETEDBasic Information
| Clinical ID | c1426 |
|---|---|
| Identifier | NCT02425865 |
| Trial Title | Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | ULCERATIVE COLITIS |
| Interventions | DRUG: GOLIMUMAB |
Participant Information
| Sponsor | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives |
|---|---|
| City | Liege |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-12-16 |
|---|---|
| Primary Completion Date | 2025-10-21 |
| Completion Date | 2025-01-23 |